Impact of Fibrosis-4 Index Prior to COVID-19 on Outcomes in Patients at Risk of Non-alcoholic Fatty Liver Disease

BACKGROUND: Severity of disease and outcomes in patient with COVID-19 has been associated with several risk factors tied to the metabolic syndrome. AIMS: We conducted a study with the objective of describing the association between the baseline Fibrosis-4 (FIB-4) index prior to SARS-CoV-2 infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Elfeki, Mohamed A., Robles, Julian, Akhtar, Zaheer, Ullah, Fauzia, Ganapathiraju, Ice, Tran, Calvin, Inman, Casey, Collin, Simon M., Rosa, Rossana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233600/
https://www.ncbi.nlm.nih.gov/pubmed/34173917
http://dx.doi.org/10.1007/s10620-021-07120-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233600/
https://www.ncbi.nlm.nih.gov/pubmed/34173917
http://dx.doi.org/10.1007/s10620-021-07120-0

Ejemplares similares